Top Markets
Coin of the day
Alpha Cognition Inc Alpha Cognition Inc

Alpha Cognition Inc

ACOG
Rank in Stocks #19835
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Share Price
$9.61
Last synced: 2026-08-25
Market Cap
$149.33M
Change (1 day)
-1.39%
Change (1 year)
21.24%
Country
US
Trade Alpha Cognition Inc (ACOG)

Category

Stock price history for Alpha Cognition Inc (ACOG)
Highest end of day price: $9.07 on 2026-08-01

Lowest end of day price: $6.45 on 2024-11-01
Stock price history of Alpha Cognition Inc from 2024 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 13.45%
2025 7.90%
2024 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$123.16 -11.88%
AU
$772.27 7.33%
CH